Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Stone and Laser Therapies Post-Market Study (SALT)

NCT: NCT06982235 · ACTIVE_NOT_RECRUITING

NCT IDNCT06982235
StatusACTIVE_NOT_RECRUITING
Start Date2025-06-30
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑